α
AlphaSteve
← Theses
Pipeline · first-read only

MP

MP Materials Corp.
Materials
Shelve
No full thesis yet — this ticker is on the pipeline. Latest first-read: Jun 8, 2026.

MP Materials (MP) — first read, 2026-06-08

1. Why it surfaced

MP is the one live capital-cycle name the research stream has carried as urgent for two weeks, and this morning's risk-off open raised the odds it gaps toward an entry 2026-06-08-AM. It traded near $64.45 in the Monday pre-market after Korea's KOSPI fell 8.29% overnight and the AI/critical-minerals complex sold off T3. This first-read also closes a documented gap: the AM/PM notes and daily scans have asserted a "live Backlog-P1 MP thesis pass" since 2026-06-03 with no artifact behind it [T1-derived: 14-Optimization/Backlog.md, "MP Materials phantom handoff" P2 item]. The file you are reading is the missing artifact.

2. Business in a paragraph

MP Materials owns and operates Mountain Pass in California, the only scaled rare-earth mine and processing site in the United States. It sells separated rare-earth oxides, chiefly NdPr oxide used in permanent magnets, and is integrating forward into magnet making at its Independence facility in Texas, with a much larger "10X" facility planned for 2028 T3. The Department of Defense is the largest shareholder at roughly a 15% effective stake through a $400M convertible preferred plus warrants, and it set a $110/kg NdPr-oxide price floor underneath the company T1. Q1 2026 was a record: revenue $132.9M, NdPr-oxide output 917 metric tons up 63% year over year, and total adjusted EBITDA of $46.3M split $36.7M Materials and $9.6M Magnetics T1. The company is reinvesting more than its operating cash flow into the magnet ramp, funded by the DoD package, a $150M strategic-capital loan, and a $1B J.P. Morgan / Goldman facility T1.

3. Back-of-envelope valuation

Item Figure Note
Price (pre-market) ~$64.45 T3
Market cap ~$11.65B T3
Q1 2026 adj. EBITDA $46.3M annualizes to ~$185M T1
EV/EBITDA (annualized Q1) ~55–60x rich; pricing the 2028 ramp, not current earnings
EPV-only floor (normalized) well below price see below

EPV here is unflattering and that is the point. Annualizing Q1 adjusted EBITDA gives ~$185M, but heavy Mountain Pass depreciation pulls normalized operating income far lower; taxed and capitalized at a 10% WACC, the earnings-power value is on the order of $1–1.5B of enterprise value, roughly $8–12 a share AS-cal. At $64 the market is paying almost entirely for the magnet ramp, the price floor, and strategic scarcity — not for earnings in the ground today. On a pure Graham-Klarman EPV basis there is no margin of safety at $64, and there would not be one at $60 either.

4. The one thing that decides this

The hinge is which frame governs the entry. MP is not an EPV deep-value name; it is an asset-value-plus-optionality name dressed in a capital cycle. The decision turns on whether the price reaches a level where the downside is hard-backstopped — the $110/kg DoD floor and the replacement value of the only US rare-earth asset — while the upside optionality on the magnet ramp is still mostly unpriced. The critical-minerals dossier places that level at $60 and argues the cohort multiple is over-extrapolating both the duration of Chinese export controls and the moat depth of Western producers 2026-05-29-critical-minerals-capital-cycle-dossier-v1. Below $60 the base-rate-adjusted asymmetry turns favorable; above it, the buyer is paying the Phase-2 premium the dossier warns against.

5. Top risk

The cleanest value-trap risk is the 2010 base rate. After the Senkaku shock, rare-earth prices ran roughly 10x, Western capacity built, China relaxed quotas, prices collapsed by 2014–2015, and Molycorp — Mountain Pass's prior owner — went bankrupt T2. The cycle peaked four to five years from the trigger. MP today trades at a multiple that embeds no Phase-3 compression, so a control relaxation or an on-time capacity build sinks the equity even with the DoD floor intact. The floor protects against price collapse, not against multiple compression.

6. Decision

Shelve with trigger at $60. The name is real and the asset is scarce, but at $64 the price still sits inside the Phase-2 premium, and the deep-value entry the dossier defines opens below $60 where the DoD floor and asset value backstop the downside. If $60 prints — a risk-off open this week could deliver it intraday — escalate to a full thesis built on asset-value and cycle triangulation, not EPV, since EPV will never carry this name. Horizon two to three quarters, anchored to the November 2026 expiry of the suspended Chinese export-control package, the cleanest forward catalyst in either direction.

Sources

Linked